PDE10A and schizophrenia: It is worth noting that PDE10A inhibitors have shown limited efficacy in schizophrenia, suggesting that findings in preclinical models may not be directly translatable to human subjects (see https://clinicaltrials.gov/ct2/show/results/NCT01175135?sect=X01256#all).